Table 1 of Abu-Amero, Mol Vis 2011; 17:1468-1472.


Table 1. mtDNA haplogroup distribution in POAG patients and controls.



Haplogroup

Coding
positions

POAG
(n=176)

HMS
(n=186)

HAS
(n=810)
POAG*
HMS
p value
POAG*
HSA
p value
H C7028C 13 (7.4%) 9 (4.8%) 66 (8.1%) 0.31 0.74
R0a T3847C 34 (19.3%) 26 (14.0%) 141 (17.4%) 0.17 0.55
J T4216C, C15452A 37 (21.0%) 47 (25.3%) 171 (21.1%) 0.34 0.98
T T4216C, G15928A 6 (3.4%) 9 (4.8%) 53 (6.5%) 0.50 0.11
K A3480G 3 (1.7%) 4 (2.2%) 27 (3.3%) 0.76 0.25
U A12308G, 12372A 16 (9.1%) 25 (13.4%) 91 (11.2%) 0.19 0.41
Other R C12705C 3 (1.7%) 8 (4.3%) 25 (3.1%) 0.15 0.32
N1 T10238C, 12501A 8 (4.5%) 13 (7.0%) 66 (8.1%) 0.25 0.04*
W G15884C 0 0 6 (0.7%) - 0.25
X C6371T 2 (1.1%) 4 (2.2%) 20 (2.5%) 0.45 0.28
M1 C10400T, 12403T 10 (5.7%) 11 (5.9%) 25 (3.1%) 0.93 0.09
M(xM1)1 C10400T 6 (3.4%) 6 (3.2%) 24 (3.0%) 0.92 0.76
L T9540C, 10400C 38 (21.6%) 24 (12.9%) 95 (11.7%) 0.03* 0.001***
L2 T10115C 11 (6.3%) 10 (5.4%) 35 (4.3%) 0.72 0.27
L(xL2)2 T9540C, 10400C 27 (15.3%) 14 (7.5%) 60 (7.4%) 0.02* 0.001***